FAKTOR-OPTIONSSCHEIN - ELI LILLY & CO | Market Closed - Boerse Frankfurt Warrants 15:46:17 2024-05-17 EDT | ||
| 440.5 EUR | -1.13% |
|
| Current month | -10.00% | ||
| 1 month | +0.74% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 24-05-17 | 442.8 | -0.63% |
| 24-05-16 | 445.6 | -6.12% |
| 24-05-15 | 474.6 | +9.87% |
| 24-05-14 | 432 | +2.94% |
| 24-05-13 | 419.7 | -1.53% |
Real-time Boerse Frankfurt Warrants
Last update May 17, 2024 at 03:46 pm
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
Société Générale
|
| WKN | SD42D5 |
| ISIN | DE000SD42D51 |
| Date issued | 2021-03-29 |
| Strike | 183.1 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 8.53 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 590.2 € |
|---|---|
| Lowest since issue | 7 € |
| Spread | 1.91 € |
| Spread % | 0.43% |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
770
USD
Average target price
850.4
USD
Spread / Average Target
+10.44%
- Stock Market
- Certificates
- Certificat
